Fenyong Liu

Title: Fenyong Liu: Innovator in Herpes Protease Research

Introduction

Fenyong Liu is a notable inventor based in Chicago, IL, who has made significant contributions to the field of virology. He holds two patents that focus on the identification and purification of herpes protease, a crucial enzyme in the herpes virus lifecycle. His work aims to advance the understanding and treatment of herpes and other viral infections.

Latest Patents

Liu's latest patents include methods and compositions for the preparation and use of a herpes protease. This invention relates to the identification and purification of a herpes protease and a nucleic acid segment coding for two proteins. The first protein is the herpes protease, which is capable of cleaving itself and the second protein. This protease is essential for the assembly of the herpes virus capsid, making it critical for viral replication. The second protein, designated as ICP35, is part of the family of proteins found in virus-infected cells. The invention also includes a promoter sequence for the second protein and methods for producing a viral protease. Additionally, it presents screening methods for protease inhibitors that may be used in drugs designed for treating herpes disease and other viral infections.

Career Highlights

Fenyong Liu is associated with Arch Development Corporation, where he continues to innovate in the field of viral research. His work has the potential to lead to new therapeutic approaches for treating herpes and similar viral infections.

Collaborations

Liu collaborates with Bernard Roizman, a prominent figure in the field of virology, enhancing the impact of his research through shared expertise.

Conclusion

Fenyong Liu's contributions to the understanding of herpes protease are invaluable in the ongoing fight against viral infections. His innovative research holds promise for developing effective treatments for herpes and other related diseases.